ZNF384 ‐Driven Fibulin‐1 Exacerbates Vascular Stiffness via TGF ‐β/Smad3‐Mediated Senescence and Fibrosis
The FASEB Journal · 31.03.2026 · 40 (6)
DOI: 10.1096/fj.202501262rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 12.03.2026. Verfasst von Dan Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Smad3 Protein, Cellular Senescence, Vascular Stiffness, Calcium-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Province Innovation Project, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Vascular stiffness, a hallmark of aging and cardiovascular disease, involves vascular smooth muscle cell (VSMC) senescence and extracellular matrix (ECM) dysregulation. This study investigates the role of fibulin‐1 (Fbln1) in these processes. Plasma proteomic profiling identified dysregulated proteins in vascular stiffness pedigrees. Fbln1 knockout mice and dual vascular stiffness models (natural aging and chronic angiotensin II [Ang II] infusion) were established. Phenotypic assessments included pulse wave velocity (PWV), histology, and molecular markers. Mechanistic investigations integrating DNA pull‐down assays, dual‐luciferase reporter assays, and RNA sequencing (RNA‐seq) were employed to dissect the transcriptional and signaling axis regulating Fbln1 expression and function. Elevated plasma Fbln1 correlated with hereditary vascular stiffness. Both aging and Ang II promote vascular stiffness, whereas Fbln1 knockdown ameliorates this phenotype by reducing PWV, reversing VSMC senescence, and attenuating collagen deposition. Zinc Finger Protein 384 (ZNF384) was identified as a transcriptional activator of Fbln1, which promoted VSMC senescence and collagen deposition via transforming growth factor‐beta (TGF‐β)/SMAD family member 3 (Smad3). Inhibiting TGF‐β/Smad3 signaling abolished Fbln1‐driven senescence and ECM remodeling. Fbln1 exacerbates vascular stiffness through ZNF384‐mediated transcriptional activation and TGF‐β/Smad3‐dependent ECM/senescence pathways. Targeting Fbln1 or its regulators may offer therapeutic strategies for age‐related vascular pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- China National GeneBank, Shenzhen, Guangdong, China.
- Department of Geriatrics Medicine. Center of Coronary Circulation, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Yong Ping Bai
Förderung
- Hubei Province Innovation Project
- the National Natural Science Foundation of China
Zitieren
APA
Yan, D., Ji, T., Liang, X., Luo, M., Huang, Y., Luo, P., Yang, Z., Zhang, L., Li, T., Bai, Y. P., Zhang, C., & Ruan, L. (2026). ZNF384 ‐Driven Fibulin‐1 Exacerbates Vascular Stiffness via TGF ‐β/Smad3‐Mediated Senescence and Fibrosis. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202501262rr
Vancouver
Yan D, Ji T, Liang X, Luo M, Huang Y, Luo P, et al. ZNF384 ‐Driven Fibulin‐1 Exacerbates Vascular Stiffness via TGF ‐β/Smad3‐Mediated Senescence and Fibrosis. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202501262rr
BibTeX
@article{Yan2026,
author = {Yan, Dan and Ji, Tianyi and Liang, Xiaolu and Luo, Mandi and Huang, Yi and Luo, Pengcheng and Yang, Zhen and Zhang, Le and Li, Tao and Bai, Yong Ping and Zhang, Cuntai and Ruan, Lei},
title = {ZNF384 ‐Driven Fibulin‐1 Exacerbates Vascular Stiffness via TGF ‐β/Smad3‐Mediated Senescence and Fibrosis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {6},
doi = {10.1096/fj.202501262rr}
}
EUVIMED